Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modelling Maternal Cytomegalovirus Seroprevalence in Australia Using Maternal Country of Birth: Implications for Antenatal Screening.

The Australian & New Zealand journal of obstetrics & gynaecology·2026

Same author

'Do You Tell Them Not to Kiss Their Child?' Implementing Congenital Cytomegalovirus Prevention Guidelines in General Practice: A Qualitative Study.

The Australian & New Zealand journal of obstetrics & gynaecology·2026

Same author

Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals.

Australian prescriber·2026

Same author

Sex Ratios at Birth Following Non-Invasive Prenatal Testing in Victoria, Australia.

Prenatal diagnosis·2026

Same author

The Right to Know About CMV-Perspectives of Pregnant Women and Families With Lived Experience of CMV.

Reviews in medical virology·2026

Same author

Implementing Publicly Funded Fetal Exome Sequencing: A Statewide Multidisciplinary Model for Equitable Integration of Genomics Into Perinatal Care.

Prenatal diagnosis·2025

Same journal

Dual antihypertensive fixed-dose combinations approved for first-line use on the Pharmaceutical Benefits Scheme.

Australian prescriber·2026

Same journal

Capivasertib for locally advanced or metastatic breast cancer.

Australian prescriber·2026

Same journal

Diagnosis and management of irritable bowel syndrome.

Australian prescriber·2026

Same journal

Stopping antidepressants: when and how.

Australian prescriber·2026

Same journal

Emergency contraception: an overview.

Australian prescriber·2026

Same journal

Sodium valproate: balancing benefits and risks especially in people of childbearing potential.

Australian prescriber·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 12, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Noninvasive prenatal testing: an overview.

Alice Poulton^1,2,3,4,5, Lisa Hui^1,2,3,4,5

¹Monash IVF Group, Melbourne.

Australian Prescriber

|May 9, 2025

Summary

This summary is machine-generated.

Noninvasive prenatal testing (NIPT) offers highly accurate screening for fetal chromosome conditions like Down syndrome. This maternal blood test aids informed decisions, though confirmatory testing is advised for high-risk results.

Keywords:

Down syndrome aneuploidy screening cell-free fetal DNA noninvasive prenatal testing prenatal screening

More Related Videos

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Related Experiment Videos

Last Updated: May 12, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Area of Science:

Genetics
Prenatal Diagnostics
Maternal Health

Background:

Australian health authorities advocate for prenatal screening for fetal chromosome conditions to support informed decision-making.
Noninvasive prenatal testing (NIPT) is a key screening method available, requiring only a maternal blood sample after 10 weeks gestation.
While not Medicare-subsidised, NIPT complements other screening methods and is recommended alongside ultrasounds for early anomaly detection.

Purpose of the Study:

To outline the role and considerations of Noninvasive Prenatal Testing (NIPT) in Australia.
To inform healthcare providers and patients about NIPT's capabilities and limitations for aneuploidy screening.
To emphasize a patient-centered approach in discussing prenatal screening options.

Main Methods:

NIPT involves analyzing cell-free fetal DNA from maternal blood.
Two primary approaches exist: genome-wide and targeted NIPT.
Evaluation of NIPT performance for common autosomal aneuploidies (trisomy 21, 18, 13).

Main Results:

NIPT demonstrates high sensitivity (true-positive rate) and specificity (low false-positive rate) for common aneuploidies.
All current NIPT platforms effectively detect trisomies 21, 18, and 13.
False-positive results are possible, necessitating further genetic counseling and diagnostic testing.

Conclusions:

NIPT is a highly effective screening tool for fetal aneuploidies, offering high accuracy.
A patient-centered approach is crucial, encouraging discussion on how results influence pregnancy decisions.
Genetic counseling and invasive testing are recommended for high-probability NIPT results, particularly if termination is considered.